A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Conditions:   Celiac Disease;   Coeliac Disease Interventions:   Drug: KAN-101;   Drug: Placebo Sponsors:   Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials